CXCR4 and ovarian cancer: In a mouse model of ovarian cancer, AMD3100 treatment showed significant increases in T-cell–mediated antitumor immune responses, resulting in CXCR4 positive tumor apoptosis and necrosis (Righi et al., 2011).